Toggle Dropdown
Groups
Announcements
Projects
Ideas
Welcome guest
Log in
Practice
My Requests
All Requests
Drill Partners
Digital games
Projects
Goals
Loading
Loading...
0
0
GSK chief says RSV vaccine will start off slower than shingles shot – but will drive future sales - CNBC
+ 111 more
7/26/23 at 4:11pm
Organization
CNBC
Author
Annika Kim Constantino
38 words
0
Comments
London-based GSK is preparing to roll out its RSV vaccine in the U.S. and European Union this fall.
Pharmaceuticals & Biotech
Business & Industrial
Company News
GSK
RSV
London
CNBC
U.S.
EU
You are the first to view
https://www.cnbc.com/2023/07/26/rsv-vaccine-uptake-will-start-slower-than-shingles-shot-gsk-ceo.html
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...